Hormones & HRT - Thyroid & fertility
Understanding TSH and thyroid blood tests
Last updated 30 September 2026. How we write this .
TSH reflects the brain's signal to the thyroid. Reading it alongside thyroid hormone levels, symptoms and context helps distinguish disease from temporary or misleading results.
Start here TSH reflects the brain's signal to the thyroid. Reading it alongside thyroid hormone levels, symptoms and context helps distinguish disease from temporary or misleading results.
By the end, you will understand The feedback loop behind TSH What the different tests measure Reading patterns rather than isolated numbers Key words used in this lesson Receptor A protein on or in a cell that a signalling molecule binds to, triggering a response. Most peptide effects are explained by binding to a particular receptor. Placebo An inactive comparison given so that the effect of expectation can be separated from the effect of the intervention itself. Without one, improvement over time cannot be attributed to the treatment. Full plain-English glossary
Where this information comes from Claim-cited evidence. Central research claims on this lesson are linked to specific studies or official guidance.
This lesson links the specific studies and guidance used for its central claims.
Our standard: expert or athlete opinion may illustrate a viewpoint, but it is never treated as proof. Read the editorial policy .
Report an error or outdated claim .
TSH and thyroid blood tests show how the body's thyroid control system is working, rather than providing a diagnosis from one number. TSH measures the pituitary gland's signal to the thyroid, while free T4 and sometimes free T3 measure circulating thyroid hormones. A result just outside a reference range is not automatically a diagnosis: its meaning depends on the pattern, symptoms, previous results and circumstances of testing.
The feedback loop behind TSH
The thyroid is a small gland in the neck that produces mainly thyroxine, called T4, and a smaller amount of triiodothyronine, called T3. Enzymes in other tissues convert T4 into T3. T3 acts through receptors that influence gene activity, affecting heat production, energy use, heart function and many other processes.
The pituitary gland, beneath the brain, releases thyroid-stimulating hormone, or TSH. When the pituitary senses insufficient thyroid hormone, it generally increases TSH to stimulate the thyroid. When it senses more thyroid hormone, it reduces TSH. This negative feedback explains an initially confusing point: a high TSH commonly suggests an underactive thyroid, rather than an overactive one.
TSH is a sensitive signal because relatively small changes in thyroid hormone can produce larger changes in TSH. However, the system takes time to reach a new balance. A result can therefore reflect an adjustment still in progress, particularly after illness or a change in prescribed thyroid medicines.
What the different tests measure
Most circulating T4 and T3 is attached to transport proteins. Free T4, abbreviated FT4, and free T3, abbreviated FT3, estimate the small unattached fractions. Total hormone measurements include both attached and unattached hormone, so changes in transport proteins can alter total results without an equivalent change in thyroid function.
For many adults, TSH is the starting test. NICE's thyroid disease guideline (NG145) describes an approach in which a raised TSH prompts FT4 measurement, while a low TSH prompts FT4 and FT3 measurement. This follows the biology: T3 can be raised in some forms of thyroid overactivity even when FT4 remains within range.
Thyroid antibodies answer a different question. Thyroid peroxidase antibodies can support an autoimmune explanation for thyroid dysfunction. TSH receptor antibodies can help identify Graves' disease, in which antibodies stimulate the thyroid. Antibodies are clues about cause, not direct measurements of hormone supply or a score of symptom severity.
Reading patterns rather than isolated numbers
Common patterns help organise an investigation, but they do not establish the cause on their own. In this context, 'primary' means that the problem originates in the thyroid gland rather than its control system.
High TSH with low FT4 commonly supports primary hypothyroidism: the pituitary is signalling harder, but thyroid hormone supply is insufficient. Low TSH with high FT4 or FT3 supports thyroid hormone excess. Further investigation distinguishes increased production from other causes. High TSH with FT4 within range is called subclinical hypothyroidism. Persistence and clinical context matter. Low TSH with FT4 and FT3 within range is called subclinical hyperthyroidism. Temporary changes and medicines can also produce this pattern. 'Subclinical' describes a laboratory pattern; it does not mean that someone cannot have symptoms. Equally, symptoms alongside that pattern do not prove that the thyroid caused them. Fatigue, constipation, poor concentration and temperature sensitivity have several possible explanations.
Thyroid hormone excess is also not always the same as excess production. An inflamed thyroid can release stored hormone without making more. This is one reason hyperthyroidism and hypothyroidism require different investigations, and why a label based on TSH alone can miss information needed to understand the condition.
Why a flagged result may be misleading
Reference ranges describe results expected in a reference population using a particular laboratory method. They are not a sharp boundary between health and disease. Laboratories can use different methods and ranges, so the units and the range printed beside a result matter more than a generic range found elsewhere.
TSH varies naturally, including across the day, and illness can temporarily alter thyroid hormone production, conversion and feedback. During recovery, TSH may rise transiently. A borderline result obtained during an acute illness may therefore have a different meaning from the same result repeatedly found when someone is otherwise well.
Biotin, included in some hair and nail supplements, can interfere with certain laboratory assays. Depending on the method, it can make thyroid results appear falsely high or low, sometimes creating a pattern that resembles thyroid overactivity. This is an effect on measurement, not necessarily a change in the thyroid itself. NICE specifically highlights biotin intake as relevant information when interpreting tests.
An unexpected result can reflect thyroid disease, a temporary physiological change or a measurement problem. The useful question is whether the laboratory pattern fits the wider picture, not simply whether a number is highlighted.
What the evidence actually establishes
The thyroid feedback mechanism is supported by extensive human physiology research and clinical observation. Thyroid blood tests are established tools for recognising clear hormone deficiency or excess. However, detailed testing pathways also incorporate expert consensus: not every decision about which test to request has been settled by a large randomised trial.
The evidence is less straightforward when the abnormality is mild and FT4 remains within range. The large, placebo-controlled TRUST trial in older adults with persistent subclinical hypothyroidism found no meaningful average improvement in thyroid-related symptoms or tiredness from levothyroxine compared with placebo. The laboratory result could improve without a corresponding improvement in how participants felt.
That finding should not be extended automatically to younger adults, pregnancy, marked abnormalities or overt hypothyroidism. These are different populations and biological situations. Evidence about symptom benefit in younger people with mild abnormalities is less certain, and trials cannot answer every question about long-term outcomes.
Observational studies associate some persistent thyroid abnormalities with heart rhythm problems and skeletal risks. These associations deserve attention, but they cannot alone prove that changing a mildly abnormal result prevents those outcomes. Age, other illnesses and medicines may influence both the test result and the later health problem.
When the usual interpretation needs adapting
The standard TSH-first approach assumes that the pituitary feedback system is functioning. With pituitary disease, FT4 can be low without an appropriately raised TSH. A TSH result within range therefore does not exclude every form of hypothyroidism. This exception matters particularly when there is known or suspected pituitary disease.
Pregnancy changes thyroid physiology and transport proteins, so pregnancy-specific interpretation is needed. Children also need age-appropriate assessment. Older adults may have different background TSH distributions and different balances of benefit and risk. A single universal 'optimal' value ignores these distinctions.
Medicines can affect the gland, hormone conversion, transport proteins or the tests themselves. Oestrogen-containing medicines can alter thyroid-binding proteins, while lithium and amiodarone can affect thyroid function through other mechanisms. People with a thyroid condition should discuss results with their care team. Self-adjusting thyroid hormone can cause serious harm; medicines should not be changed based on a consumer device or an isolated home result. The NHS website explains thyroid conditions and when to see a GP.
Judging claims and recognising safety limits
Claims about 'optimal thyroid health' often blur three separate questions: whether a result is unusual, whether thyroid disease explains it, and whether changing it improves health. Credible explanations keep these questions separate. They identify the population studied and report outcomes such as symptoms or daily functioning, rather than presenting a shifted blood result as proof of benefit.
More tests do not automatically mean better understanding. A useful additional test answers a specific uncertainty. A broad panel can instead produce incidental flags that encourage unsupported explanations. Likewise, a normal thyroid result does not make persistent symptoms imaginary; it may mean that another explanation needs consideration.
For safety, stop exertion if palpitations occur with chest pain, breathlessness or feeling faint. NHS guidance advises calling 999 for current palpitations that do not go away, or palpitations with these warning symptoms. If those symptoms have stopped, contact a GP urgently or NHS 111; recurring palpitations without emergency features also warrant GP assessment. A recent thyroid result cannot rule out an urgent heart problem.
This lesson is general education, not medical advice, and is not a recommendation to start, stop or change any hormone treatment. Your GP, practice nurse or a specialist can discuss what fits your history.
Related in this classroom The studies behind this page Recommendations: thyroid disease assessment and management - NICE guideline NG145, reviewed 2025Sources for this classroom
Educational content only. Not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional before changing your health regimen.